Clinical Trials Directory

Trials / Completed

CompletedNCT00581204

Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose for this study is to measure the physiology of human undergoing a Lower Body Negative Pressure usea non-invasive low-power optical technique, near-infrared diffuse optical spectroscopy measurement and compare these measurement to standard monitoring procedures delineated in the Brooke Army Medical Center. The Brooke Army Medical Center can use near-infrared diffuse optical spectroscopy to provide functional physiologic tissue and organ information without ionizing radiation and without withdrawing any blood, in a cost-effective and rapid manner. Monitoring for the onset of circulatory shock in a wounded soldier on the battlefield is typically performed by measurement of arterial blood pressure, arterial oxygen saturation, or simple auscultation of the pulse. Shock is typically recognized by non-specific signs and subjective symptoms such as cold clammy skin, pallor, weak thready pulse, unstable vital signs, and diminished mentation.

Detailed description

The near-infrared diffuse optical spectroscopy can measure tissue regions deeper below the skin surface and reports on larger tissue volumes in muscle and brain. The near-infrared diffuse optical spectroscopy instrument generate harmless amounts of low-level non-ionizing near-infrared ligh can measure the tissue absorption and scattering properties at depths of 1 cm or more below the skin surface include larger tissue volumes in muscle and brain. The absorption properties of tissue provide and can determine absolute concentrations of deoxygenated hemoglobin, oxygenated hemoglobin, and water, as well as the total hemoglobin saturation.

Conditions

Interventions

TypeNameDescription
DEVICENear-Infrared Diffuse Optical SpectroscopyEarly predictor of hemorrhagic shock

Timeline

Start date
2011-12-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2007-12-27
Last updated
2022-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00581204. Inclusion in this directory is not an endorsement.